Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Neutralizing antibodies and anti COVID-19 vaccines.

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: CBS-005
  • By: GALVáN GONZáLEZ, Manuel Ángel (Colegio Oficial de Farmacéuticos de Santa Cruz de Tenerife, Spain)
  • Co-author(s): Mr Manuel Ángel Galván González, President (Colegio Oficial de Farmacéuticos de Santa Cruz de Tenerife, Santa Cruz de Tenerife, Spain)
    Mr Basilio Valladares Hernández (Universidad de La Laguna, La Laguna, Spain)
    Mr Francisco Miranda Saavedra, Secretary (Colegio Oficial de Farmacéuticos de Santa Cruz de Tenerife, Santa Cruz de Tenerife, Spain)
    Mrs Victoria Revilla Calvo, Direction (Colegio Oficial de Farmacéuticos de Santa Cruz de Tenerife, Santa Cruz de Tenerife, Spain)
    Mr Manuel Oliver Sánchez (Colegio Oficial de Farmacéuticos de La Palmas, Las Palmas de Gran Canaria, Spain)
    Mr Roberto Dorta Guerra (Colegio Oficial de Farmacéuticos de La Palmas, Las Palmas de Gran Canaria, Spain)
    Mrs Noelia Fernández Ramos (Hospital San Juan de Dios, Santa Cruz de Tenerife, Spain)
    Mrs María Eugenia Curbelo, Direction (Colegio Oficial de Farmacéuticos de La Palmas, Las Palmas de Gran Canaria, Spain)
    Mrs María Loreto Gómez Guedes, President (Colegio Oficial de Farmacéuticos de La Palmas, Las Palmas de Gran Canaria, Spain)
  • Abstract:

    INTRODUCTION
    Problems and uncertainties generated by COVID 19 regarding different types of vaccines and number of doses to be administered, led the Official Pharmacist Society of the Canary Islands (COFSCTFE) to carry out an effectiveness study according to the vaccine, number of doses and the presence or absence of diagnosed COVID 19 in..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses